HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

International Cancer Research Conference

March 24-26, 2025 | Singapore

March 24 -26, 2025 | Singapore

Cancer Research 2025

Speaker at International Cancer Research Conference 2025 - Farid Moinfar
Keynote Presentation (In-Person)
Farid Moinfar, Ordensklinikum Linz Barmherzige Schwestern, Austria

Introduction: Basal-like breast carcinomas are immunohistochemically positive for basal-type keratins such as K 5/6, K14, and K17 and mostly are triple-negative (negativity for ER, PR, and Her2/neu). “Basal-like” or triple-negative breast carcinoma is mostly known as [....] » Read More

Speaker at International Cancer Research Conference 2025 - Vandana Tiwari
Keynote Presentation (In-Person)
Vandana Tiwari, Dr. Ram Manohar Lohia Institute of Medical Sciences, India

Background: Oral squamous cell carcinoma (OSCC) is a leading malignancy with high mortality and poor prognosis. Dysregulation of endoplasmic reticulum stress response (ERSR) genes and circular RNAs (circRNAs) contributes to its tumorigenesis and progression. Aim: This study ai [....] » Read More

Speaker at International Cancer Research Conference 2025 - Getachew Dagne
Oral Presentation (In-Person)
Getachew Dagne, University of South Florida, United States

Background: Examining spatial distribution of colorectal cancer (CRC) incidence or mortality is helpful for developing cancer control and prevention programs, or for generating hypotheses. Such an investigation involves describing the spatial variation of risk factors for colorec [....] » Read More

Speaker at International Cancer Research Conference 2025 - Namrata P Awasthi
Oral Presentation (In-Person)
Namrata P Awasthi, Dr. Ram Manohar Lohia Institute of Medical Sciences, India

Background: The lecture will introduce the audience to commonly utilized techniques for Cytology of malignant fluids including cytospin, cell block and immunohistochemistry. The advantages and limitations of the techniques will be discussed. Further, basics of flow cytometry (FCM [....] » Read More

Speaker at International Cancer Research Conference 2025 - Amir Ashraf
Oral Presentation (In-Person)
Amir Ashraf, Dr. Amir’s Family Homoeopathy Clinic, India

Homoeopathy is an alternative system of medicine discovered by German physician Samuel Hahnemann in 1796. It has been used by several people for various health conditions globally for more than last 200 years. In India, homoeopathy is considered as a major system of alternative m [....] » Read More

Speaker at International Cancer Research Conference 2025 - Zainab Awada
Oral Presentation (In-Person)
Zainab Awada, Sidra Medicine, Qatar

Background: Childhood acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, yet significant inter-individual variability exists in response to its therapy. Genetic polymorphisms as biomarkers for treatment efficacy and toxicity in childhood ALL are limited, part [....] » Read More

Speaker at International Cancer Research Conference 2025 - Shivam Singh
Oral Presentation (In-Person)
Shivam Singh, All India Institute of Medical Sciences, India

Background: The incidence of breast cancer has increased while the mortality rate has continued to remain high. Effective treatment of this disease is the key to survival. Therefore, this study is a necessity in continuing research into new effective treatments. According to anci [....] » Read More

Speaker at International Cancer Research Conference 2025 - Yuxin Zhu
Oral Presentation (In-Person)
Yuxin Zhu, Nanchang University, China

Pancreatic cancer (PC), characterized by aggressive progression and poor prognosis, poses a critical global health challenge. This multinational study investigates epidemiological disparities in PC incidence and disease burden through a socio-demographic index (SDI)-stratified an [....] » Read More

Speaker at International Cancer Research Conference 2025 - Redolen Rose Dhar
Oral Presentation (In-Person)
Redolen Rose Dhar, Manipal Academy of Higher Education, India

Background: Cancer is the leading cause of death worldwide, with the WHO projecting a 45% increase in global cancer deaths from 2008 to 2030 (1, 2). Beyond health impacts, cancer imposes significant economic strains, particularly on younger, low-income individuals (3). The extens [....] » Read More

Speaker at International Cancer Research Conference 2025 - Divyapriya Karthikeyan
Oral Presentation (In-Person)
Divyapriya Karthikeyan, InDspireX, India

ROS1 (Receptor Tyrosine Kinase ROS Proto-Oncogene 1) mutations in non-small cell lung cancer (NSCLC) lead to the formation of chimeric proteins that activate key oncogenic signaling pathways, contributing to tumorigenesis. These mutations, including ROS1 gene rearrangements such [....] » Read More

Speaker at International Cancer Research Conference 2025 - Phyu Ou Maung
Oral Presentation (In-Person)
Phyu Ou Maung, University of Dental Medicine, Myanmar

Background: Oral squamous cell carcinoma (OSCC) has become a major oncologic problem. Survivin overexpression in OSCC could be associated with increased aggressiveness, poor response to chemotherapy and prediction of patient survival. This study was conducted to analyze the mRNA [....] » Read More

Speaker at International Cancer Research Conference 2025 - Changqin Pu
Oral Presentation (In-Person)
Changqin Pu, Peking Union Medical College Hospital, China

Objective: Pituitary adenomas (PAs) are clinically heterogeneous tumors with subtype-specific hormonal profiles, yet current therapies remain largely reactive and fail to address their proliferative core. This study challenges the dogma of subtype-driven tumorigenesis by ide [....] » Read More

Speaker at International Cancer Research Conference 2025 - Congcong Deng
Oral Presentation (In-Person)
Congcong Deng, Peking Union Medical College Hospital, China

Refractory pituitary adenomas (RPAs) and pituitary carcinomas (PCs) present significant therapeutic challenges, as they often do not respond to conventional treatment modalities such as surgery, radiation, and traditional medical therapies. Temozolomide (TMZ), an alkylating chemo [....] » Read More

Speaker at International Cancer Research Conference 2025 - Jian Li
Oral Presentation (In-Person)
Jian Li, Shanghai Jiaotong University, China

Conventional neoadjuvant chemotherapy offers limited benefit for patients with resectable non-small-cell lung cancer (NSCLC). Recently, neoadjuvant chemoimmunotherapy (NCIT) has transformed perioperative management of NSCLC by priming systemic anti-tumor immunity before surgery, [....] » Read More

Speaker at International Cancer Research Conference 2025 - Changjiang Yang
Oral Presentation (In-Person)
Changjiang Yang, Peking University People's Hospital, China

Recent research has linked Importin7 to cancer aggressiveness and a dismal prognosis, but its function in colorectal cancer (CRC) is unclear. This study aimed to elucidate the clinical relevance, biological function, and potential molecular mechanisms of IPO7 in CRC. Our results [....] » Read More

Speaker at International Cancer Research Conference 2025 - Pauline Picho Keronyai
Oral Presentation (In-Person)
Pauline Picho Keronyai, Nama Wellness Community Centre (NAWEC), Uganda

Cervical cancer remains a significant public health challenge in Africa, with the continent bearing approximately 19% of global cases. The East African region reports particularly concerning statistics, with an age-standardized incidence rate of 40.1 per 100,000 women annually, s [....] » Read More

Speaker at International Cancer Research Conference 2025 - Li Mian Er
Oral Presentation (In-Person)
Li Mian Er , The Fourth Hospital of Hebei Medical University, China

Objective:Endoscopic submucosal dissection (ESD) is widely used for early esophageal cancer,but the post-ESD stricture rate of patients with a post-ESD mucosal defect of ≥ 3/4 of the esophageal circumference is extremely high(even reach 90%).Long term repeated endoscopic dilat [....] » Read More

Speaker at International Cancer Research Conference 2025 - Chanchan Gao
Poster Presentation (In-Person)
Chanchan Gao, Zhongda Hospital, Southeast University, China

Objective: This study aimed to investigate the role of RGS2 in immune regulation and its impact on the efficacy of PD-1/PD-L1 blockade therapy in lung cancer (LC), as well as to explore the regulatory relationship between RGS2 and BATF2 in modulating T cell exhaustion and tumor i [....] » Read More

Speaker at International Cancer Research Conference 2025 - Yuchun Niu
Poster Presentation (In-Person)
Yuchun Niu, Oncology Hospital of the First People's Hospital of Foshan, China

Understanding the Role of Super-enhancer MYCNOS-SE in Chemoresistance of Small Cell Lung Cancer. Small cell lung cancer (SCLC) is a highly aggressive malignancy characterized by rapid progression and a high propensity for chemotherapy resistance. This presentation will discuss [....] » Read More

Speaker at International Cancer Research Conference 2025 - Jian Li
Poster Presentation (In-Person)
Jian Li, Shanghai Jiaotong University, China

Neoadjuvant immunotherapy with anti-programmed death-1 (neo-antiPD1) has revolutionized perioperative treatment for improving the overall survival (OS) of patients with early-stage lung cancer. Despite its transformative impact, neo-antiPD1 provides limited benefit to nearly 50% [....] » Read More

Speaker at International Cancer Research Conference 2025 - Pietro Salvatori
Keynote Presentation (Virtual)
Pietro Salvatori, Independent H&N Surgeon, Italy

Treatment goals for Head & Neck cancers can be indicated as: 1) Eradication of the tumor (ablative surgery or XRT, combinations), 2) Restoration of the anatomy (reconstructive surgery), 3) Rehabilitation of the function. Of course, the main goals are to increase survi [....] » Read More

Speaker at International Cancer Research Conference 2025 - Bene Ekine-Afolabi
Keynote Presentation (Virtual)
Bene Ekine-Afolabi, University of East London, United Kingdom

Drug metabolism is crucial in any functioning of a drug, particularly in drugs for cancer treatment. Several drugs do not function in human body in their original state unless metabolised to its required functioning metabolite to affect its target organ/site or tissue. Drug metab [....] » Read More

Speaker at International Cancer Research Conference 2025 - Paulo Cesar De Morais
Keynote Presentation (Virtual)
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil

Poly(lactic-co-glycolic acid) (PLGA) nanoparticle has proven extremely useful for drug delivery, thanks to its high biocompatibility, biodegradability, and toxicologically safe degradation products. This talk will emphasize the use of nanosized (~140 nm mean diameter) PLGA loaded [....] » Read More

Speaker at International Cancer Research Conference 2025 - Michael Thompson
Keynote Presentation (Virtual)
Michael Thompson, University of Toronto, Canada

Biosensor technology represents an attractive strategy for the detection and monitoring of biomarkers for disease states within the context of precision medicine. This approach offers the possibility for biomarker assay via incorporation into an automated robotic system to proces [....] » Read More

Speaker at International Cancer Research Conference 2025 - Rajvir Dahiya
Keynote Presentation (Virtual)
Rajvir Dahiya, University of California San Francisco, United States

Background: Current screening methods, have limitations in the diagnosis and prognosis of prostate cancer. This study examined whether mRNA-genomic biomarkers can improve screening and monitoring of prostate cancer. Methods: We identified a panel of 25 prostate cancer-related [....] » Read More

Speaker at International Cancer Research Conference 2025 - Xiangning Zhang
Oral Presentation (Virtual)
Xiangning Zhang, Guangdong Medical University, China

On short arm of human chromosome 3, a region 3p21, which is deleted in a variety of tumors, harbors a cluster of putative tumor suppressor genes (TSGs). One of the TSG candidates, BLU, coding for a zinc protein ZMYND10 has initially recognized as a fragment lost in lung cancers. [....] » Read More

Speaker at International Cancer Research Conference 2025 - Wenzhe Si
Oral Presentation (Virtual)
Wenzhe Si, Peking University Third Hospital, China

Background: Metabolic reprogramming and epigenetic alterations contribute to the aggressiveness of pancreatic ductal adenocarcinoma (PDAC). Lactate-dependent histone modification is a new type of histone mark, which links glycolysis metabolite to the epigenetic process of la [....] » Read More

Speaker at International Cancer Research Conference 2025 - Saumya Pandey
Oral Presentation (Virtual)
Saumya Pandey, Indira IVF Hospital, India

Objective: Dissecting the cellular/molecular/genetic regulatory biochemical signaling networks: Autophagy/Toll-like Receptors/Wnt-Frizzled in inflammatory “gastrohepatic disease-web” primarily hepatocellular/colorectal/cholangiocarcinomas is essential for diminishing [....] » Read More

Speaker at International Cancer Research Conference 2025 -  Luiza Simonyan
Oral Presentation (Virtual)
Luiza Simonyan, L. Orbeli Institute of Physiology of the National Academy of Sciences of Armenia, Armenia

Modern medical methods of treatment allow in some cases to prevent the development of pathological processes in the human body. It is known that the effectiveness of such therapeutic effects is largely determined by the possibility of diagnosing the disease at the initial stages [....] » Read More

Speaker at International Cancer Research Conference 2025 - Özlem Terzi
Oral Presentation (Virtual)
Özlem Terzi, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Turkey

Febrile neutropenia (FEN) is the most common life-threatening complication of childhood cancer. Early initiation of broad-spectrum intravenous antibiotics to patients has reduced the mortality of FEN below 5%. Studies have reported viral infections to constitute 35 to 55% of FEN [....] » Read More

Speaker at International Cancer Research Conference 2025 - Ibrahim El Bayoumy
Oral Presentation (Virtual)
Ibrahim El Bayoumy, Consultant of Public Health-Ministry of Health, Kuwait

Background Colorectal cancer accounts for approximately 10% of all annually diagnosed cancers and cancer-related deaths worldwide.1 It is the second most common cancer diagnosed in women and third most in men. In women, incidence and mortality are approximately 25% lower than in [....] » Read More

Speaker at International Cancer Research Conference 2025 - Nayara Delgado André Bortoleto
Oral Presentation (Virtual)
Nayara Delgado André Bortoleto, Federal University of Sao Joao del Rei, Portugal

Breast cancer is the most prevalent malignancy in women worldwide and remains a leading cause of cancer-related mortality. Immune system controls tumor progression but is often suppressed in breast cancer. Dendritic cells (DCs), essential for linking innate and adaptive immunity, [....] » Read More

Speaker at International Cancer Research Conference 2025 - Marie Fusella Giuntini
Oral Presentation (Virtual)
Marie Fusella Giuntini, University of Corsica, France

Each year, a high number of new cases of thyroid cancer are identified. Although this disease has a good prognosis, it is often immediately metastatic, which requires removal of the thyroid body, followed by iratherapy (administration of iodine 131) in order to eradicate the vari [....] » Read More

Speaker at International Cancer Research Conference 2025 - Eleni Petsalaki
Oral Presentation (Virtual)
Eleni Petsalaki, University of Crete, Greece

Chromatin bridges are strands of incompletely segregated DNA connecting the anaphase poles or daughter nuclei. Chromatin bridges can arise from incompletely replicated DNA, defective resolution of DNA catenates or dicentric chromosomes which are formed by chromosome fusions. If u [....] » Read More

Speaker at International Cancer Research Conference 2025 - Maurice T. Agonnoude
Oral Presentation (Virtual)
Maurice T. Agonnoude, Parakou University, Benin

Introduction: The integration of breast cancer screening into daily clinical care leads to an early diagnosis and reduces its mortality. However, many women are reluctant and do not get tested. Objective To study the factors associated with the practice of breast cancer scre [....] » Read More

Speaker at International Cancer Research Conference 2025 - Dago Dougba Noel
Oral Presentation (Virtual)
Dago Dougba Noel, PELEFORO GON COULIBALY University, Cote d'Ivoire

Cancers are genetic and epigenetic diseases in which cells divide and grow in uncontrolled ways due to mutations or molecular alterations. Gene fusion phenomena is recurrent in cancer cells. One of the most common cancers is breast cancer, representing worldwide public health con [....] » Read More

Speaker at International Cancer Research Conference 2025 - Shuaiqi Wang
Poster Presentation (Virtual)
Shuaiqi Wang, Chongqing University Cancer Hospital, China

Background: We developed the laparoscopic and endoscopic cooperative surgery (LECS) technique, which combines non-exposed wall-inversion surgery (NEWS) and sentinel node navigation surgery (SNNS) to treat early gastric cancer (EGC). It is a technique which preserves organ functio [....] » Read More

Speaker at International Cancer Research Conference 2025 - Hao Sun
Poster Presentation (Virtual)
Hao Sun, Chongqing University Cancer Hospital, China

Background: We developed the laparoscopic and endoscopic cooperative surgery (LECS) technique, which combines non-exposed wall-inversion surgery (NEWS) and sentinel node navigation surgery (SNNS) to treat early gastric cancer (EGC). It is a technique which preserves organ functio [....] » Read More

Speaker at International Cancer Research Conference 2025 - Somashekhar SP
Poster Presentation (Virtual)
Somashekhar SP, Aster CMI Hospital, India

Introduction: HR+/HER2-negative Early Breast Cancer (EBC) is treated with curative intent, but managing locoregional and distant recurrences remains a significant challenge. The lack of a standard risk-identification approach leads to varied assessments across centers. Developi [....] » Read More

Speaker at International Cancer Research Conference 2025 - Marika Crohns
Keynote Presentation (Virtual)
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates

Artificial Intelligence (AI) has emerged as a transformative force in oncology, offering unparalleled potential to revolutionize cancer care. By leveraging advanced algorithms and machine learning models, AI enhances every phase of the cancer care continuum—from early detec [....] » Read More

Speaker at International Cancer Research Conference 2025 - Michele Mishto
Keynote Presentation (Virtual)
Michele Mishto, Francis Crick Institute, United Kingdom

MHC class I complexes can present antigenic peptides that have a sequence produced by post-translational mechanisms such as peptide splicing. Some examples of tumour-associated spliced epitopes have been investigated for their immunogenicity in the context of cancer so far. We de [....] » Read More

Speaker at International Cancer Research Conference 2025 - Patricia Tai
Keynote Presentation (Virtual)
Patricia Tai, UpToDate, United States

About 2 in 5 Canadians are expected to be diagnosed with cancer in their lifetime and 1 in 4 die of it. I would discuss interesting updates of advances in cancer research. Biomarker assays have become routine for some cancers. Circulating tumor cells/cell-free deoxyribonucleic [....] » Read More

Speaker at International Cancer Research Conference 2025 - Atif A Ahmed
Keynote Presentation (Virtual)
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States

RNA binding proteins (RBPs) are regulators of RNA metabolism and influence protein expression in various physiologic and pathologic conditions through regulation of RNA splicing, stability and translation. Several studies have demonstrated that RBPs play a role in cancer developm [....] » Read More

Speaker at International Cancer Research Conference 2025 - Anyou Wang
Keynote Presentation (Virtual)
Anyou Wang, DIFIBER LLC, United States

Numerous cancer-related mechanisms are reported daily, yet a universal theory for eradicating all cancers remains elusive. Fortunately, recent advances in big data and AI have identified noncoding RNAs as central players in all cancers, challenging the conventional protein-centri [....] » Read More

Speaker at International Cancer Research Conference 2025 - Liling Jiang
Oral Presentation (Virtual)
Liling Jiang, Shapingba District People's Hospital of Chongqing, China

All studies were performed on a 3 T whole-body MRI system (MAGNETOM Prisma, Siemens Healthineers, Erlangen, Germany) using a 16-channel surface coil (Zhongzhi Medical, Jiangsu). Firstly, we evaluated the thyroid nodule image quality between two diffusion weighted imaging (DWI) te [....] » Read More

Speaker at International Cancer Research Conference 2025 - Jiawei Guo
Oral Presentation (Virtual)
Jiawei Guo, Sichuan University, China

Bromodomain and extra-terminal (BET) family members, including BRD2, BRD3, BRD4 and BRDT, function as critical readers of acetylated histones and globally activate oncogene expression. These proteins have emerged as attractive epigenetic targets for cancer therapy, with more th [....] » Read More

Speaker at International Cancer Research Conference 2025 - Ratan Kumar Sarkar
Oral Presentation (Virtual)
Ratan Kumar Sarkar, Independent Researcher, India

The molecular weights of amino acids are time values where integer and decimal part have separate identity but interrelated. Derived from the factor 14.0267 e.g. 119.1197(Thr) – 105.0930(Ser) = 14.0267 = 131.1736(Leu) – 117.1469(Val), the formula T(time) = 0.0019*M(in [....] » Read More

Speaker at International Cancer Research Conference 2025 - Prabha Muddobalaiah
Oral Presentation (Virtual)
Prabha Muddobalaiah, Ramaiah Institute of Technology, India

Glioblastoma Multiforme G IV primary malignant Brain tumor medications such as Radiation, Surgery, Gene therapy, Chemotherapy and Ayurveda which are not very much successful with clinical studies. However, the trials are being made towards the various cancers’ successful tr [....] » Read More

Speaker at International Cancer Research Conference 2025 - Gaurav Vishal
Oral Presentation (Virtual)
Gaurav Vishal, Prathima Cancer Institute, India

Squamous cell carcinoma (SCC) is the most common malignant neoplasm of the oral cavity. SCC is a major health problem for the world. Based on GLOBOCAN estimates, about 377,713 new cancer patients and 177,757 deaths occurred in 2020 worldwide. The load of oral squamous cell carc [....] » Read More

Speaker at International Cancer Research Conference 2025 - K R Muralidhar
Oral Presentation (Virtual)
K R Muralidhar, Karkinos Healthcare, India

The discussion will be on optimum utilization of AI and genomics in delivering personalized treatments inRadiationOncology for better treatment outcome. Artificial Intellignce , Machine learing and Deep learning will bediscussedand the future of artificial intelligence in radiati [....] » Read More

Speaker at International Cancer Research Conference 2025 - Sinem Durmus
Oral Presentation (Virtual)
Sinem Durmus, Izmir Katip Celebi University, Turkey

Oxidative stress is one of major factors of cancer initiation and progression by inducing damage to cellular macromolecules through the accumulation of reactive oxygen species (ROS). This process contributes to tumor development by triggering events such as DNA mutations, protein [....] » Read More

Speaker at International Cancer Research Conference 2025 - Sara Mokbel
Oral Presentation (Virtual)
Sara Mokbel, University College London, United Kingdom

Background: Immune checkpoint inhibitors (ICIs) improve overall survival (OS) in advanced/metastatic urothelial cancer (a/mUC) patients. Preliminary evidence suggests a prognostic role of inflammatory biomarkers in this setting. We aimed to develop a disease-specific prognostic i [....] » Read More

Speaker at International Cancer Research Conference 2025 - Oleg Bukhtoyarov
Oral Presentation (Virtual)
Oleg Bukhtoyarov, Medical Center 39 LLC, Russian Federation

Undoubtedly, cancer refers to the group called “diseases of civilization”. Over the last 100 years, cancer has become a real nightmare for humanity. Despite having the tremendous world scientific and financial resources, successes in the cancer research and treatment, [....] » Read More

Speaker at International Cancer Research Conference 2025 - Abdel Ghany F. Shoair
Oral Presentation (Virtual)
Abdel Ghany F. Shoair, Damietta University, Egypt

A novel ruthenium(III) complex with 2-aminomethyl benzimidazole (AMBI) has been synthesized and characterized by elemental analysis, spectroscopic (FTIR, UV–Vis and XRD), thermal, magnetic and electrochemical techniques. Characterization shown that the ruthenium ion is oc [....] » Read More

Speaker at International Cancer Research Conference 2025 - Andrea González Báez
Oral Presentation (Virtual)
Andrea González Báez, Autonomous University of Nuevo Leon, Mexico

Cancer is a complex pathology of great relevance for public health due to its high mortality and morbidity. Specifically breast cancer, is one of the main causes of death in women worldwide, demonstrating that its incidence has been exponentially uprising. The multifactorial natu [....] » Read More

Speaker at International Cancer Research Conference 2025 - Patricia Tai
Oral Presentation (Virtual)
Patricia Tai, UpToDate, United States

Introduction: Photodynamic therapy (PDT) promotes wound healing while its clinical use is not investigated in human for radiation-induced skin ulcers. Methods and Materials: We documented the first Canadian in-human case and searched the PubMed literature using “PDT" [....] » Read More

Speaker at International Cancer Research Conference 2025 - Zahra Husain
Oral Presentation (Virtual)
Zahra Husain, Government Hospital, Bahrain

Background: Sarcopenia has been shown to be an independent predictor of lower overall survival in oncology patients. Several studies have used computed tomography (CT) to measure psoas muscle surface area to define sarcopenia. However, the cut-off values based on CT imaging [....] » Read More

Speaker at International Cancer Research Conference 2025 - Can Küçük
Oral Presentation (Virtual)
Can Küçük, Dokuz Eylul University, Turkey

Burkitt lymphoma is the most common non-Hodgkin lymphoma in children. Pediatric Burkitt lymphomas (pBLs) are characterized by fast tumor growth; therefore, rapid diagnosis and initiation of therapy is of utmost significance. MicroRNAs (miRNAs) are small non-coding RNAs that were [....] » Read More

Watsapp